Gammagard and Conjunctivitis - a phase IV clinical study of FDA data

Summary:

Conjunctivitis is reported as a side effect among people who take Gammagard (immune globulin), especially for people who are female, 60+ old, also take Singulair, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Conjunctivitis when taking Gammagard. It is created by eHealthMe based on reports of 8,933 people who have side effects when taking Gammagard from the FDA, and is updated regularly.

What is Gammagard?

Gammagard has active ingredients of immune globulin. eHealthMe is studying from 8,948 Gammagard users. Check the latest studies of Gammagard.

What is Conjunctivitis?

Conjunctivitis (pink eye) is found to be associated with 1,298 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Conjunctivitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

8,933 people reported to have side effects when taking Gammagard.
Among them, 31 people (0.35%) have Conjunctivitis.

Among these 31 people:

What is the gender of people who have Conjunctivitis when taking Gammagard? *

female: 87.1 %
male: 12.9 %

What is the age of people who have Conjunctivitis when taking Gammagard? *

What are other drugs people take besides Gammagard? *

What are other side effects people have besides Conjunctivitis? *

Sinusitis (inflammation of sinus): 15 people, 48.39%
Urinary Tract Infection: 11 people, 35.48%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 22.58%
Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 16.13%
Asthma: 5 people, 16.13%
Headache (pain in head): 4 people, 12.90%
Respiratory Tract Infection: 4 people, 12.90%
Pneumonia: 4 people, 12.90%
Dehydration (dryness resulting from the removal of water): 4 people, 12.90%
Infusion Site Swelling: 4 people, 12.90%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 27 people, 87.10%
Primary Immunodeficiency Syndrome: 6 people, 19.35%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 19.35%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 5 people, 16.13%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 3.23%
Humoral Immune Defect (impairment of humoral immunity): 1 person, 3.23%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Gammagard and have Conjunctivitis?

- Check whether Conjunctivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gammagard:

Gammagard (8,948 reports)

Conjunctivitis treatments and more:

Conjunctivitis (22,439 reports)

Browse all side effects of Gammagard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis:

Conjunctivitis (1,298 drugs)

Browse all the conditions that are associated with Conjunctivitis:

Conjunctivitis (1,644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on immune globulin (the active ingredients of Gammagard) and Gammagard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.